Daniel R. Vlock

1.1k total citations
32 papers, 916 citations indexed

About

Daniel R. Vlock is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Daniel R. Vlock has authored 32 papers receiving a total of 916 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 14 papers in Radiology, Nuclear Medicine and Imaging and 12 papers in Oncology. Recurrent topics in Daniel R. Vlock's work include Monoclonal and Polyclonal Antibodies Research (13 papers), Immunotherapy and Immune Responses (12 papers) and CAR-T cell therapy research (5 papers). Daniel R. Vlock is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), Immunotherapy and Immune Responses (12 papers) and CAR-T cell therapy research (5 papers). Daniel R. Vlock collaborates with scholars based in United States, Ireland and South Korea. Daniel R. Vlock's co-authors include John M. Kirkwood, Marc S. Ernstoff, Maria Karayiorgou, Linda Titus‐Ernstoff, Jane W. Fountain, Alan N. Houghton, Vijayasaradhi Setaluri, Brigitte Bouchard, Jill M. Lahti and George L. Adams and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Daniel R. Vlock

32 papers receiving 898 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel R. Vlock United States 17 447 332 299 163 153 32 916
Stephen M. Thirdborough United Kingdom 21 494 1.1× 452 1.4× 562 1.9× 261 1.6× 95 0.6× 31 1.3k
Yoshinori Suminami Japan 19 337 0.8× 521 1.6× 339 1.1× 332 2.0× 93 0.6× 41 1.2k
Melanie Straub Germany 10 518 1.2× 426 1.3× 439 1.5× 66 0.4× 144 0.9× 19 913
Boris Kubuschok Germany 21 511 1.1× 472 1.4× 594 2.0× 121 0.7× 242 1.6× 49 1.5k
Mark Egan United Kingdom 17 372 0.8× 701 2.1× 175 0.6× 179 1.1× 207 1.4× 27 1.4k
Derek Atkins Germany 20 544 1.2× 568 1.7× 478 1.6× 176 1.1× 98 0.6× 27 1.5k
Pradip Nair India 14 231 0.5× 383 1.2× 180 0.6× 109 0.7× 103 0.7× 22 767
Lazar Vujanović United States 19 588 1.3× 318 1.0× 648 2.2× 112 0.7× 31 0.2× 39 1.1k
Gabriella Della Torre Italy 20 578 1.3× 518 1.6× 179 0.6× 235 1.4× 140 0.9× 47 1.3k
Arjen Brink Netherlands 23 470 1.1× 446 1.3× 119 0.4× 263 1.6× 34 0.2× 41 1.2k

Countries citing papers authored by Daniel R. Vlock

Since Specialization
Citations

This map shows the geographic impact of Daniel R. Vlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Vlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Vlock more than expected).

Fields of papers citing papers by Daniel R. Vlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Vlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Vlock. The network helps show where Daniel R. Vlock may publish in the future.

Co-authorship network of co-authors of Daniel R. Vlock

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Vlock. A scholar is included among the top collaborators of Daniel R. Vlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Vlock. Daniel R. Vlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Cywes‐Bentley, Colette, Angela I. Bordin, Tanweer Zaidi, et al.. (2018). Antibody to Poly-N-acetyl glucosamine provides protection against intracellular pathogens: Mechanism of action and validation in horse foals challenged with Rhodococcus equi. PLoS Pathogens. 14(7). e1007160–e1007160. 35 indexed citations
3.
4.
Logan, Theodore F., Merrill J. Egorin, Mark A. Mintun, et al.. (2002). Decreased tumor blood flow as measured by positron emission tomography in cancer patients treated with interleukin-1 and carboplatin on a phase I trial. Cancer Chemotherapy and Pharmacology. 50(6). 433–444. 18 indexed citations
5.
Logan, Theodore F., William E. Gooding, Marc S. Ernstoff, et al.. (1997). Biologic Response Modulation by Tumor Necrosis Factor Alpha (TNFα) in a Phase Ib Trial in Cancer Patients. Journal of Immunotherapy. 20(5). 387–398. 6 indexed citations
6.
Vlock, Daniel R., Janet Andersen, Leslie A. Kalish, et al.. (1996). Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates. Journal of Immunotherapy. 19(6). 433–442. 23 indexed citations
7.
Vlock, Daniel R., Eugene N. Myers, David E. Eibling, et al.. (1994). Phase Ib Trial of the Effect of Peritumoral and Intranodal Injections of Interleukin-2 in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck: An Eastern Cooperative Oncology Group Trial. Journal of Immunotherapy. 15(2). 134–139. 33 indexed citations
8.
9.
Johnson, Candace S., Weidong Yu, Ruth A. Modzelewski, et al.. (1993). Synergistic enhancement by interleukin-1 ? of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice. Cancer Chemotherapy and Pharmacology. 32(5). 339–346. 15 indexed citations
10.
Selvaggi, Kathy, Elizabeth A. Saria, R H Schwartz, et al.. (1993). Phase I/II Study of Murine Monoclonal Antibody-Ricin A Chain (XOMAZYME-Mel) Immunoconjugate plus Cyclosporine A in Patients with Metastatic Melanoma. Journal of Immunotherapy. 13(3). 201–207. 42 indexed citations
11.
Vlock, Daniel R., et al.. (1993). Isolation and purification of a squamous cell carcinoma of the head and neck-associated antigen identified by autologous antibody. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1181(2). 174–182. 6 indexed citations
12.
Gersten, Douglas M., et al.. (1993). Cross-reactivity between murine melanoma antigen B700 and a human melanoma-associated antigen (M-66) recognized by autologous antibody: evidence suggesting shared epitopes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1182(1). 51–56. 3 indexed citations
13.
Vlock, Daniel R., et al.. (1992). Modulation by interferon α and γ of the expression of a melanoma-associated antigen detected by autologous antibody. Melanoma Research. 2(2). 105–114. 2 indexed citations
14.
Vlock, Daniel R., Beth Arnold, Donald R. Schwartz, et al.. (1992). Serial studies of autologous antibody reactivity to squamous cell carcinoma of the head and neck. Cancer Immunology Immunotherapy. 34(5). 329–336. 9 indexed citations
15.
Fountain, Jane W., Maria Karayiorgou, Marc S. Ernstoff, et al.. (1992). Homozygous deletions within human chromosome band 9p21 in melanoma.. Proceedings of the National Academy of Sciences. 89(21). 10557–10561. 257 indexed citations
16.
Vlock, Daniel R., et al.. (1991). Purification and partial characterization of a shed 66 kDa melanoma-associated antigen identified by autologous antibody. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 1080(1). 1–10. 5 indexed citations
17.
Vlock, Daniel R., Jonas T. Johnson, Eugene Myers, et al.. (1991). Preliminary trial of nonrecombinant interferon alpha in recurrent squamous cell carcinoma of the head and neck. Head & Neck. 13(1). 15–21. 35 indexed citations
18.
Luger, S. M., John M. Kirkwood, Marc S. Ernstoff, & Daniel R. Vlock. (1990). High-Dose Cisplatin and Dacarbazine in the treatment of Metastatic Melanoma. JNCI Journal of the National Cancer Institute. 82(24). 1934–1937. 15 indexed citations
19.
Vlock, Daniel R., et al.. (1988). Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.. Journal of Clinical Investigation. 81(6). 1746–1751. 15 indexed citations
20.
Kirkwood, John M., Daniel R. Vlock, Ronald D. Neumann, et al.. (1983). Tomographic Gallium-67 Citrate Scanning Useful New Surveillance for Metastatic Melanoma. Annals of Surgery. 198(1). 102–107. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephen M. Thirdborough Breakdown of academic impact, for papers by Yoshinori Suminami Breakdown of academic impact, for papers by Melanie Straub Breakdown of academic impact, for papers by Boris Kubuschok Breakdown of academic impact, for papers by Mark Egan Breakdown of academic impact, for papers by Derek Atkins Breakdown of academic impact, for papers by Pradip Nair Breakdown of academic impact, for papers by Lazar Vujanović Breakdown of academic impact, for papers by Gabriella Della Torre Breakdown of academic impact, for papers by Arjen Brink
Rankless by CCL
2026